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Abstract: An UHPLC-MS/MS method for the quantification of tomato phenolic metabolites in
human fluids was optimized and validated, and then applied in a pilot dietary intervention study
with healthy volunteers. A 5-fold gain in speed (3.5 min of total run); 7-fold increase in MS
sensitivity and 2-fold greater efficiency (50% peak width reduction) were observed when comparing
the proposed method with the reference-quality HPLC-MS/MS system, whose assay performance
has been previously documented. The UHPLC-MS/MS method led to an overall improvement in
the limits of detection (LOD) and quantification (LOQ) for all the phenolic compounds studied. The
recoveries ranged between 68% and 100% in urine and 61% and 100% in plasma. The accuracy; intra-
and interday precision; and stability met with the acceptance criteria of the AOAC International
norms. Due to the improvements in the analytical method; the total phenolic metabolites detected
in plasma and urine in the pilot intervention study were 3 times higher than those detected by
HPLC-MS/MS. Comparing with traditional methods; which require longer time of analysis; the
methodology described is suitable for the analysis of phenolic compounds in a large number of
plasma and urine samples in a reduced time frame.
Keywords: polyphenol metabolites; validation; tomato; sauce; microbiota; metabolites; biosamples;
blood; urine
1. Introduction
Tomato (Solanum lycopersicum) is a food very rich in bioactive compounds such as vitamins
or carotenoids and it contains a variety of phenolic compounds [1]. Phenolics play an important
protective role in human health, decreasing mortality [2], cardiovascular disease [3], and DNA
oxidation [4], and counteracting age-related cognitive decline [5]. The most important phenolics
described in tomato and tomato by-products belong to hydroxycinnamic acids, flavanones and
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flavonols, specifically, naringenin, rutin or 5-caffeoylquinic acid [6,7]. After ingestion, polyphenols
are metabolized in the small intestine and liver producing a series of metabolites (methyl,
glucuronide, and sulfate), which may pass into the blood stream, accumulate in tissues, and then
excreted in urine [8].
An exhaustive identification of polyphenols in food and biological samples is of great interest
due to their health-promoting effects. Although a wide range of methods have been reported for the
detection of phenolic compounds in food, beverages, or biological samples (i.e., spectrophotometry,
capillary electrophoresis, near-infrared spectroscopy, HPLC-UV-DAD) [9–12], liquid chromatography
coupled to mass spectrometry (LC-MS) [13–18] is the most commonly used technique due to its high
sensitivity and selectivity.
In particular, ultra-high performance liquid chromatography (UHPLC) enhances
chromatographic separation by using columns packed with smaller particles (1.7 µm), which
provides higher resolution and better efficiency than conventional chromatography [19]. It also
offers compatibility with high back-pressure operating conditions (up to 15,000 psi), which in turn
increases mobile phase viscosity and the capacity to dissolve analytes [12]. The resulting higher peak
resolution and shorter run times translates into lower analytical costs, and is more “environmentally
friendly” in terms of reduced generation of hazardous chemical waste [20].
The aim of this work was to improve the efficiency and resolution of the HPLC-ESI-QqQ
MS/MS method validated previously by our research group [21] for the detection and
quantification of 5 hydroxycinnamic acids, 4 hydroxyphenylacetic acids, 2 hydroxybenzoic acids,
1 hydroxyphenylpropionic acid, 1 flavanone and 2 flavonols. Thus a new UHPLC-MS/MS-driven
method was developed which involved the optimization of the main LC (column, elution solvents
and gradients) and MS operating conditions (declustering potential (DP), focusing potential (FP) and
collision energy (CE)), followed by its application in a pilot tomato sauce dietary intervention study.
2. Results
2.1. UHPLC-MS/MS Method Development
Table 1 shows the LOD and LOQ obtained for each compound when the study of the
optimum mobile phase was achieved. Homovanillic acid, phenylacetic acid, quercetin and
quercetin-3-O-glucuronide up to 100 ng/mL were not detected using 0.1% and 0.05% formic acid,
whereas 0.025% formic acid allowed the detection and quantification of all the target compounds.
H2O (0.025% formic acid)/MeCN (0.025% formic acid) improved the LOD of 3-hydroxyphenylacetic
acid, dihydrocaffeic acid, ferulic acid, and above all isoferulic acid.
Declustering potential (DP), focusing potential (FP), entrance potential (EP), quantification and
confirmation transitions with their corresponding collision energy (CE) were shown in Table 2
obtaining the optimum value for the mass conditions.
The flow rate, which allowed a correct resolution of the compounds, was achieved with
600 µL/min of H2O (0.025% formic acid)/MeCN (0.025% formic acid) and the best volume injection
was obtained with 10 µL.
Comparing a standard mix in the HPLC-MS/MS (Figure 1A) and UHPLC-MS/MS (Figure 1B)
systems, the latter provided adequate resolution in less time. The UHPLC equipment allowed the
quantification of 16 phenolic compounds in 3.5 min in comparison with 12 min needed for the
HPLC analysis.
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Table 1. LOD and LOQ of an aqueous mix of 15 phenolic compounds (100 ng/mL) in the study of different mobile phases by UHPLC-MS/MS.
Compounds
LOD a (ng/mL) (n = 3) c LOQ b (ng/mL) (n = 3) c
Formic Acid
(0.1%)
Formic Acid
(0.05%)
Formic Acid
(0.025%)
Formic Acid
(0.1%)
Formic Acid
(0.05%)
Formic Acid
(0.025%)
Caffeic acid 1.7 ˘ 0.1 2.2 ˘ 0.1 2.1 ˘ 0.4 5.6 ˘ 0.5 7.4 ˘ 0.1 6.8 ˘ 1.3
5-Caffeoylquinic acid 0.8 ˘ 0.3 1.8 ˘ 0.3 5.3 ˘ 0.4 2.7 ˘ 0.9 6.1 ˘ 0.8 17.6 ˘ 1.3
Dihydrocaffeic acid 10.7 ˘ 0.6 6.9 ˘ 0.4 6.0 ˘ 0.2 35.7 ˘ 1.6 23.1 ˘ 0.9 19.8 ˘ 0.7
3,4-Dihydroxyphenylacetic acid 2.8 ˘ 0.3 8.2 ˘ 0.3 2.3 ˘ 0.4 9.5 ˘ 0.8 27.3 ˘ 1.1 7.5 ˘ 1.5
Ferulic acid 5.5 ˘ 0.6 1.8 ˘ 0.2 1.9 ˘ 0.4 18.3 ˘ 1.8 5.9 ˘ 0.7 6.2 ˘ 1.1
Hippuric acid 12.5 ˘ 1.7 9.6 ˘ 2.5 9.4 ˘ 0.9 41.5 ˘ 5.8 32.0 ˘ 2.1 31.5 ˘ 2.5
Homovanillic acid n.d. d n.d. d 49.2 ˘ 2.4 n.d. d n.d. d 163.9 ˘ 6.8
4-Hydroxyhippuric acid 0.6 ˘ 0.1 1.3 ˘ 0.2 2.5 ˘ 0.4 2.1 ˘ 0.6 4.2 ˘ 0.8 8.3 ˘ 1.4
3-Hydroxyphenylacetic acid 12.0 ˘ 1.3 7.1 ˘ 0.3 6.6 ˘ 0.6 39.8 ˘ 3.6 23.7 ˘ 0.7 21.8 ˘ 2.1
3-(3-Hydroxyphenyl)propionic acid 5.7 ˘ 0.9 6.6 ˘ 0.2 3.4 ˘ 0.1 18.9 ˘ 2.7 22.0 ˘ 0.5 11.2 ˘ 0.5
Isoferulic acid 54.6 ˘ 2.2 5.9 ˘ 0.1 8.9 ˘ 0.9 181.8 ˘ 8.4 19.6 ˘ 0.4 29.7 ˘ 3.3
Naringenin 0.5 ˘ 0.1 0.4 ˘ 0.2 0.7 ˘ 0.4 1.6 ˘ 0.4 1.2 ˘ 0.8 2.4 ˘ 1.1
Phenylacetic acid n.d. d n.d. d 35.3 ˘ 3.0 n.d. d n.d. d 117.7 ˘ 8.9
Quercetin n.d. d n.d. d 21.9 ˘ 0.9 n.d. d n.d. d 73.0 ˘ 2.3
Quercetin-3-O-glucuronide n.d. d n.d. d 22.4 ˘ 0.2 n.d. d n.d. d 74.6 ˘ 0.2
Values are means ˘ standard deviation; LOD a: limit of detection; LOQ b: limit of quantification; (n = 3) c: replicates; n.d. d: no detected.
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Table 2. Rt (Retention time), Declustering potential (DP), focusing potential (FP) and entrance potential (EP) optimized. Quantification and confirmation transitions
of the phenolic compounds with the optimum collision energy (V).
Compounds Rt (Min) DP (V) FP (V) EP (V) QuantificationTransition
Collision
Energy (V)
Confirmation
Transition
Collision
Energy (V)
Caffeic acid 1.18 ´40 ´170 ´10 179Ñ 135 ´20 179Ñ 107 ´30
5-Caffeoylquinic acid 1.01 ´50 ´180 ´10 353Ñ 191 ´20 353Ñ 179 ´30
Dihydrocaffeic acid 1.12 ´50 ´170 ´10 181Ñ 137 ´20 181Ñ 121 ´30
3.4-Dihydroxyphenylacetic acid 0.83 ´40 ´170 ´10 167Ñ 123 ´10
Ethylgallate (IS) 1.56 ´60 ´200 ´10 197Ñ 169 ´25 197Ñ 124 ´40
Ferulic acid 1.70 ´40 ´170 ´10 193Ñ 134 ´20 193Ñ 178 ´30
Hippuric acid 1.10 ´40 ´170 ´10 178Ñ 134 ´20
Homovanillic acid 1.27 ´40 ´170 ´10 181Ñ 137 ´20
4-Hydroxyhippuric acid 0.68 ´40 ´170 ´10 194Ñ 100 ´20 194Ñ 150 ´30
3-Hydroxyphenylacetic acid 1.28 ´40 ´170 ´10 151Ñ 107 ´10
3-(3-Hydroxyphenyl)propionic acid 1.67 ´40 ´170 ´10 165Ñ 121 ´20 165Ñ 119 ´35
Isoferulic acid 1.80 ´50 ´220 ´10 193Ñ 178 ´20 193Ñ 134 ´35
Naringenin 2.51 ´50 ´190 ´10 271Ñ 151 ´30 271Ñ 119 ´40
Phenylacetic acid 1.10 ´50 ´170 ´10 135Ñ 91 ´30
Quercetin 2.46 ´60 ´210 ´10 301Ñ 151 ´30 301Ñ 179 ´40
Quercetin-3-O-glucuronide 1.76 ´60 ´210 ´10 477Ñ 301 ´30 477Ñ 151 ´40
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Figure 1. Chromatograms of standards solution obtained by HPLC-MS/MS (A) and UHPLC-MS/MS 
(B) analysis. Chromatograms of urine at 6 h (C), plasma at 1 h (D) and tomato sauce (E). Peaks: (1)  
4-hydroxyhippuric acid; (2) hippuric acid; (3) dihydrocaffeic acid; (4) 5-caffeoylquinic acid; (5) caffeic 
acid; (6) ethylgallate (IS); (7) 3-(3-hydroxyphenyl)propionic acid; (8) ferulic acid; (9) isoferulic acid; 
(10) quercetin; (11) naringenin; (12) 3,4-dihydroxyphenylacetic acid; (13) homovanillic acid; (14)  
3-hydroxyphenylacetic acid; (15) phenylacetic acid; (16) quercetin-3-O-glucuronide; (17) ferulic acid 
glucuronide; (18) caffeic acid sulfate; (19) ferulic acid sulfate; (20) naringenin glucuronide; (21) caffeic 
acid hexoside; (22) homovanillic acid hexoside; (23) rutin; (24) hydroxybenzoic acid.  
2.2. Validation Parameters 
2.2.1. Limits of Detection (LOD) and Quantification (LOQ) 
The sensitivity of the method was evaluated by determining the LOD and LOQ. There were no 
differences in LOD and LOQ values between the two biosamples (urine and plasma) (Table 3). 
Nevertheless, the results showed a wide range of sensitivity according to the analyte. LOD were 
established between 0.5 and 62.5 ng/mL in urine and 0.3 and 44.1 ng/mL in plasma. In the case of 
LOQ, values ranged from 1.8 to 203.4 ng/mL in urine and 1.6 to 145.8 ng/mL in plasma. The most 
notable improvement was for 4-hydroxyhippuric acid and isoferulic acid, whose LOD decreased 
25-fold and 15-fold in urine and 11-fold and 9-fold in plasma, respectively if HPLC and UHPLC 
were compared. The LOD for ferulic and hippuric acids also decreased, particularly in plasma, but 
to a lesser extent. 
 
Figure 1. Chro atograms of standards solution obtained by HPLC-MS/MS (A) and UHPLC-MS/ S
( ) l sis. Chro atogra s of urine at 6 h (C), plasm at 1 h (D) and tomato sauce (E). Peaks:
(1) 4-hydroxyhippuri acid; (2) hippuric acid; (3) ihydrocaffeic acid; (4) 5-caffeoylquinic acid; (5)
caffeic acid; (6) ethylgallate (IS); (7) 3-(3-h droxyphenyl)propionic acid; (8) ferulic acid; (9) isoferulic
acid; (10) quercetin; (11) naringenin; (12) 3,4-dihydroxyphenylacetic acid; (13) ho ovani lic (14)
3-hydroxyphenylacetic acid; (15) phenylacetic acid; (16) q ercetin-3- -glucuronide; (17) ferulic acid
glucuronide; (18) caf eic acid sulfate; (19) ferulic acid s lfate; (20) ari e i l c ronide; (21) caffeic
acid hexoside; (22) ho ovanil ic acid hexoside; (23) rutin; (24) hydroxybenzoic acid.
2.2. ali atio ara eters
2.2.1. i its f etecti ( ) an uantification (L )
he i i i t ethod was evaluated by determining the LOD and LOQ. There were
no differences in LOD and LOQ values between the two biosamples (urine a l 3).
evertheless, t e res lts sho ed a i e ra ge of se siti it cc r ing to t e a al te. ere
established et ee . L in urine and 0.3 and 4.1 ng/mL in plasma. In the case
of LOQ, values ranged from 1.8 to 203.4 ng/mL in urine and 1.6 to 145.8 ng/mL in plasma. The
m st notable improvement was for 4-hydroxyhippuri acid and isoferulic acid, hose ecrease
25-fol and 15-fold in urine and 11-fold and 9-fold in plasm , respectiv ly if HPLC and UHPLC were
compared. The LOD for ferulic and hippuric acids also decreased, particularly in plasma, but to a
lesser extent.
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Table 3. LOD, LOQ, recovery, concentration range and correlation coefficient in urine and plasma samples by HPLC-MS/MS and UHPLC-MS/MS.
Compounds
HPLC (n = 3) a UHPLC (n = 3) a HPLC (n = 3) a UHPLC (n = 3) a HPLC UHPLC
URINE PLASMA URINE PLASMA URINE PLASMA URINE PLASMA URINE PLASMA URINE PLASMA
LOD b
(ng/mL)
LOQ c
(ng/mL)
LOD b
(ng/mL)
LOQ c
(ng/mL)
LOD b
(ng/mL)
LOQ c
(ng/mL)
LOD b
(ng/mL)
LOQ c
(ng/mL)
Rec. e
(%)
Rec. e
(%)
Rec. e
(%)
Rec. e
(%)
Conc.
Range f
(ng/mL)
(r2) g
Conc.
Range f
(ng/mL)
(r2) g
Conc.
Range f
(ng/mL)
(r2) g
Conc.
Range f
(ng/mL)
(r2) g
Caffeic acid 1.5˘ 0.1 6.0˘ 0.1 1.8˘ 0.1 6.0˘ 0.4 0.5˘ 0.2 2.0˘ 0.4 0.7˘ 0.1 2.8˘ 0.1 97˘ 4 98˘ 3 100˘ 2 91˘ 2 6–3450(0.990)
6–3450
(0.993)
2–1152
(0.994)
3–1728
(0.995)
5-Caffeoylquinic acid 0.5˘ 0.1 2.0˘ 0.2 0.6˘ 0.1 2.0˘ 0.1 1.1˘ 0.1 4.3˘ 0.1 0.5˘ 0.1 1.7˘ 0.1 103˘ 2 99˘ 4 99˘ 4 92˘ 2 2–1150(0.999)
2–1150
(0.999)
4–2304
(0.992)
2–1152
(0.998)
Dihydrocaffeic acid 6.3˘ 0.2 25˘ 0.9 4.4˘ 0.1 15˘ 0.3 5.7˘ 0.6 20.2˘ 2.1 5.3˘ 0.3 18.0˘ 1.0 101˘ 2 104˘ 5 97˘ 5 90˘ 4 25–14,400(0.993)
15–14,400
(0.991)
20–11,520
(0.996)
18–10,368
(0.992)
3,4-Dihydroxyphenylacetic acid n.s. d n.s. d n.s. d n.s. d 1.1˘ 0.1 3.5˘ 0.2 1.6˘ 0.1 5.4˘0.2 n.s. d n.s. d 78˘ 3 69˘ 2 n.s. d n.s. d 4–2304(0.994)
5–2880
(0.998)
Ferulic acid 15˘ 0.7 50˘ 2.7 18˘ 2.1 60˘ 7.0 1.9˘ 0.1 6.6˘ 0.2 1.6˘ 0.1 5.6˘ 0.2 95˘ 2 98˘ 4 100˘ 4 100˘ 3 50–28,800(0.990)
60–28,800
(0.996)
7–4032
(0.998)
6–3456
(0.990)
Hippuric acid 25˘ 1.6 80˘ 3.2 25˘ 0.8 90˘ 2.1 4.4˘ 0.2 15.0˘ 0.6 2.1˘ 0.3 6.5˘ 0.9 106˘ 2 99˘ 4 97˘ 2 99˘ 4 80–51,840(0.990)
90–51,840
(0.992)
15–8640
(0.999)
7–4032
(0.991)
Homovanillic acid n.s. d n.s. d n.s. d n.s. d 4.5˘ 0.1 17.3˘ 0.4 8.5˘ 0.3 29.2˘ 1.0 n.s. d n.s. d 97˘ 4 92˘ 4 n.s. d n.s. d 17–9792(0.996)
29–16,704
(0.991)
4-Hydroxyhippuric acid 15˘ 1.2 50˘ 2.6 15˘ 0.7 50˘ 3.2 0.6˘ 0.1 1.8˘ 0.2 1.4˘ 0.1 4.6˘ 0.3 75˘ 3 73˘ 3 68˘ 3 61˘ 4 50–28,800(0.990)
50–28,800
(0.992)
2–1152
(0.999)
5–2880
(0.999)
3-Hydroxyphenylacetic acid n.s. d n.s. d n.s. d n.s. d 0.9˘ 0.1 2.8˘ 0.2 1.6˘ 0.3 5.3˘ 0.9 n.s. d n.s. d 99˘ 2 98˘ 2 n.s. d n.s. d 3–1728(0.999)
5–2880
(0.998)
3-(3-Hydroxyphenyl)propionic
acid 6.0˘ 0.8 20˘ 1.4 6.0˘ 1.2 20˘ 2.9 2.5˘ 0.1 9.0˘ 0.2 2.4˘ 0.2 8.6˘ 0.5 97˘ 2 99˘ 5 98˘ 4 94˘ 3
20–11,520
(0.995)
20–11,520
(0.994)
9–5184
(0.991)
9–5184
(0.994)
Isoferulic acid 29˘ 4.3 90˘ 13.6 30˘ 2.4 105˘ 8.0 2.0˘ 0.3 6.2˘ 1.0 3.4˘ 0.2 12.0˘ 0.5 99˘ 2 99˘ 4 100˘ 3 97˘ 4 90–28,800(0.997)
105–28,800
(0.994)
6–3456
(0.993)
12–6912
(0.993)
Naringenin 0.5˘ 0.1 2.0˘ 0.1 0.5˘ 0.1 2.0˘ 0.1 0.6˘ 0.1 2.8˘ 0.3 0.3˘ 0.1 1.6˘ 0.1 104˘ 4 96˘ 3 99˘ 2 96˘ 2 2–1150(0.999)
2–1150
(0.995)
3–1728
(0.999)
2–1152
(0.999)
Phenylacetic acid n.s. d n.s. d n.s. d n.s. d 62.5˘ 3.0 203.4˘ 9.9 44.1˘ 5.4 145.8˘ 17.8 n.s. d n.s. d 95˘ 3 99˘ 4 n.s. d n.s. d 203–116,929(0.992)
146–84,096
(0.994)
Quercetin 1.7˘ 0.1 6.0˘ 0.3 1.4˘ 0.1 5.0˘ 0.4 2.3˘ 1.4 8.5˘ 4.8 4.5˘ 0.1 15.8˘ 0.3 65˘ 3 100˘ 3 85˘ 4 100˘ 2 6–3450(0.991)
5–3450
(0.990)
9–5184
(0.998)
16–9216
(0.998)
Quercetin-3-O-glucuronide n.s. d n.s. d n.s. d n.s. d 1.4˘ 0.1 4.4˘ 0.1 1.9˘ 0.1 6.1˘ 0.2 n.s. d n.s. d 99˘ 2 95˘ 2 n.s. d n.s. d 5–2880(0.997)
6–3456
(0.993)
Values are means˘ standard deviation; (n = 3) a: replicates; LOD b: limit of detection; LOQ c: limit of quantification; n.s. d: not studied; Rec. e: recovery; Conc. Range f: concentration
range; (r2) g: correlation coefficient.
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2.2.2. Linearity
Calibration curves showed linear responses between LOQ and 576 times LOQ for each analyte,
establishing ranges from 2 ng/mL to 116,929 ng/mL in urine, and 2 ng/mL to 84,096 ng/mL in
plasma. A weighting factor was necessary for almost all the phenolic compounds studied to achieve
accuracy between 85%–115%. The correlation coefficient (r2) between 0.990 and 0.999 for plasma
and 0.991 and 0.999 for urine demonstrate an adequate linearity, similarly of those obtained in the
HPLC-MS/MS validation [21].
2.2.3. Recovery
Table 3 shows the recoveries obtained with UHPLC system and the previous HPLC method
validation. In the HPLC system, the recovery of the compounds studied ranged from 65% to
106% in urine and 73% to 104% in plasma. The lowest recovery in urine was for quercetin, and
4-hydroxyhippuric acid in plasma. In the case of UHPLC, there was little variation between the
two biological matrices, with recoveries greater than 85% except for 3,4-dihydroxyphenylacetic
acid and 4-hydroxyhippuric acid (78% in urine and 69% in plasma, and 68% in urine and 61% in
plasma, respectively).
2.2.4. Accuracy and Precision
Intra- and interday accuracy and precision were studied by injection of plasma and urine extracts
spiked at three different concentrations: low (3-fold the LOQ), medium (48-fold the LOQ), and high
(288-fold the LOQ). The accuracy obtained was between 91.3% and 113.9% in urine, and 99.0%
and 114.8% in plasma, thereby meeting with the AOAC acceptance criteria. Phenylacetic acid was
the phenolic acid in urine with both the highest intra- and interday accuracy. In plasma, the top
percentage was given by homovanillic acid. Intra- and interday precision studies gave the same
results as for accuracy. No polyphenol in urine or plasma samples exceeded the 15% RSD set by the
AOAC. The highest values were 3.6% RSD in urine, corresponding to 4-hydroxyhippuric acid, and
13.5% RSD in plasma, to quercetin.
2.2.5. Stability
The processed sample stability refers to the variation of concentration, since the SPE is performed
until the samples are in the autosampler, in this case about 24 h. The results show a reduction in
concentration ranging between 3.0% for caffeic acid and 12.9% for phenylacetic acid in urine, and
2.8% for homovanillic acid and 13.3% for quercetin in plasma, but without significant differences
between the biological samples and standards. For the freeze/thaw stability, three freeze-thaw cycles
were assessed for a mix of the standards used for the validation in plasma and urine samples.
Similar results were obtained, with a reduction ranging from 3.1% for dihydrocaffeic acid to 12.6%
for quercetin in urine, and 3.8% for 3-hydroxyphenylacetic acid to 9.1% for quercetin in plasma.
2.3. Phenolic Quantification in Tomato Sauce and Biological Samples
Figure 2 shows the concentration of the phenolic compounds in the tomato sauce administered
to the eight volunteers. The main polyphenols present in the tomato sauce were from two classes:
flavonoid and phenolic acids, the latter represented by a wider range of compounds (mono-, di- and
tricaffeoylquinic acids, caffeic acid and two hexosides, ferulic acid hexoside, two coumaric acid
hexosides, protocatechuic acid, and homovanillic acid hexoside). Homovanillic acid hexoside was
the predominant polyphenol in the sauce (0.140 ˘ 0.005 mg/g FW) highlighting above the rest
of compounds. Flavanones and flavonols were also found in the tomato sauce being naringenin
and rutin the compounds with higher concentration, 6.650 ˘ 0.003 and 5.390 ˘ 0.015 µg/g
FW, respectively.
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Figure 2. Quantification of phenolic compounds from tomato sauce administered to the volunteers 
by UHPLC-MS/MS analysis. Values are mean ± standard deviation (µg/g FW). Diccaffeoylquinic acid 
was expressed as ng/g FW and homovanillic acid hexoside as mg/g FW.  
Table 4 shows the concentration of phenolic compounds found in plasma and urine after the 
tomato sauce intervention. Twelve phenolic compounds were quantified in plasma and twenty-eight 
in urine by UHPLC-MS/MS. The concentration ranged between 2.7 to 183 ng/mL in plasma for 
5-caffeoylquinic acid and caffeic acid sulfate, respectively, and between 17.0 to 33188 ng/mL for 
5-caffeoylquinic acid and 4-hydroxyhippuric acid, respectively. A great variety of metabolites 
belonging to microbiota were quantified in urine at high concentrations as 16,425 ng/mL for 
3-hydroxyphenylacetic acid sulfate or 225,696 ng/mL for ferulic acid sulfate. 
Table 4. Phenolic compounds and metabolites quantified in urine and plasma by UHPLC-MS/MS. 
Compounds 
Product Ions in MS2
Experiments 
Urine (ng/mL) Plasma (ng/mL) 
Caffeic acid * 179,135,107 206 (4.0–822) n.d. a 
Caffeic acid glucuronide (CA) 355,179,135,175,113 54.9 (2.0–975) 6.4 (3.0–12.1) 
Caffeic acid sulfate (CA) 259,179,135 1396 (10.2–42286) 183 (15.3–862) 
5-Caffeoylquinic acid * 353,191,179 17.0 (7.2–53.6) 2.7 (2.0–3.5) 
Dihydrocaffeic acid * 181,137,59 194.7 (30.1–1031.9) n.d. a 
Dihydrocaffeic acid glucuronide (DHCA) 357,181,137,175,113 2127 (23–10071) n.d. a 
Dihydrocaffeic acid sulfate (DHCA) 261,181,137 2775 (52–9424) n.d. a 
3,4-Dihydroxyphenylacetic acid * 167,123 1095 (33.9–2249) n.d. a 
Ferulic acid * 193,134,175 453 (31–2139) 8.1 (6.5–40.3) 
Ferulic acid glucuronide (FA) 369,193,134,175,113 2852 (110–69495) 53.5 (6.7–1881) 
Ferulic acid sulfate (FA) 273,193,134 22569 (713–536479) 95.5 (24.5–316) 
Homovanillic acid * 181,137 4050 (1073–9387) n.d. a 
4-Hydroxyhippuric acid * 194,100 33188 (691–214695) n.d. a 
3-Hydroxyphenylacetic acid * 151,107 739 (244–1291) n.d. a 
3-Hydroxyphenylacetic acid glucuronide (3-HPAA) 327,151,107,175,113 295 (11.0–1608) n.d. a 
3-Hydroxyphenylacetic acid sulfate (3-HPAA ) 231,151,107 16425 (175–352967) n.d. a 
3-(3-Hydroxyphenyl)propionic acid * 165,121 1402 (188–4007) n.d. a 
  
Figure 2. Quantification of phenolic compounds from tomato sauce administered to the volunteers by
UHPLC-MS/MS analysis. Values are mean ˘ standard deviation (µg/g FW). Diccaffeoylquinic acid
was expressed as ng/g FW and homovanillic acid hexoside as mg/g FW.
Table 4 shows the concentration of phenolic compounds found in plasma and urine after the
tomato sauce intervention. Twelve phenolic compounds were quantified in plasma and twenty-eight
in urine by UHPLC-MS/MS. The concentration ranged between 2.7 to 183 ng/mL in plasma for
5-caffeoylquinic acid and caffeic acid sulfate, respectively, and between 17.0 to 33,188 ng/mL
for 5-caffeoylquinic acid and 4-hydroxyhippuric acid, respectively. A great variety of metabolites
belonging to microbiota were quantified in urine at high concentrations as 16,425 ng/mL for
3-hydroxyphenylacetic acid sulfate or 225,696 ng/mL for ferulic acid sulfate.
Table 4. Phenolic compounds and metabolites quantified in urine and plasma by UHPLC-MS/MS.
Compounds Product Ions in MS
2
Experiments Urine (ng/mL) Plasma (ng/mL)
Caffeic acid * 179,135,107 206 (4.0–822) n.d. a
Caffeic acid glucuronide (CA) 355,179,135,175,113 54.9 (2.0–975) 6.4 (3.0–12.1)
Caffeic acid sulfate (CA) 259,179,135 1396 (10.2–42,286) 183 (15.3–862)
5-Caffeoylquinic cid * 353,191,179 17.0 (7.2–53.6) 2.7 (2.0–3.5)
Dihydrocaffeic acid * 181,137,59 194.7 (30.1– 031.9) n.d. a
Dihydrocaffeic acid glucuronide
(DHCA) 357,181,137,175,113 2127 (23–10,071) n.d.
a
Dihydrocaffeic acid sulfate (DHCA) 261,181,137 2775 (52–9424) n.d. a
3,4-Dihydroxyphenylacetic acid * 167,123 1095 (33.9–2249) n.d. a
Ferulic acid * 193,134,175 453 (31–2139) 8.1 (6.5–40.3)
Ferulic acid glucuronide (FA) 369,193,134,175,113 2852 (110–69,495) 53.5 (6.7–1881)
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Table 4. Cont.
Compounds Product Ions in MS
2
Experiments Urine (ng/mL) Plasma (ng/mL)
Ferulic acid sulfate (FA) 273,193,134 22,569 (713–536,479) 95.5 (24.5–316)
Homovanillic acid * 181,137 4050 (1073–9387) n.d. a
4-Hydroxyhippuric acid * 194,100 33,188 (691–214,695) n.d. a
3-Hydroxyphenylacetic acid * 151,107 739 (244–1291) n.d. a
3-Hydroxyphenylacetic acid
glucuronide (3-HPAA) 327,151,107,175,113 295 (11.0–1608) n.d.
a
3-Hydroxyphenylacetic acid sulfate
(3-HPAA) 231,151,107 16,425 (175–352,967) n.d.
a
3-(3-Hydroxyphenyl)propionic acid * 165,121 1402 (188–4007) n.d. a
3-(3-Hydroxyphenyl)propionic acid
glucuronide (3-(3-HPPA)) 341,165,121,175,113 258 (15.3–4914) n.d.
a
3-(3-Hydroxyphenyl)propionic acid
sulfate (3-(3-HPPA)) 245,165,121 3156 (27.6–145,199) n.d.
a
Isoferulic acid * 193,134,175 1156 (247–3427) 108 (10.6–494)
Naringenin * 271,151,119 39.1 (6.9–400) 11.7 (2.0–52.6)
Naringenin glucuronide (N) 854 (214–1558.5) 73.4 (2.0–830)
Phenylacetic acid * 135,91 1129 (297–6667) n.d. a
Phenylacetic acid glucuronide (PAA) 311,135,91,175,113 318 (206–431) n.d. a
Phenylacetic acid sulfate (PAA) 215,135,91 1378 (110–26,708) n.d. a
Quercetin * 301,151,179 70.8 (9.1–417) 99.0 (23.7–331)
Quercetin glucuronide * 477,301,151,175,113 14.4 (11.9–101) 20.9 (14.3–63.4)
Quercetin sulfate (Q) 381,301,151 32.0 (11.9–489.8) 3.8 (3.5–4.2)
Values are median (minimum-maximum values); *: commercial standard; n.d. a: not detected; CA: Caffeic
Acid; DHCA: Dihydrocaffeic Acid; FA: Ferulic Acid; 3-HPAA: 3-Hydroxyphenylacetic acid; 3-(3-HPPA):
3-(3-Hydroxyphenyl)propionic acid; N: Naringenin; PAA: Phenylacetic acid; Q: Quercetin.
3. Discussion
3.1. UHPLC-MS/MS Method Development
Before the validation of the method, different mobile phases were tested to obtain the best
detection and separation of the compounds (Table 1). Between the three phases studied, 0.1%, 0.05%
and 0.025% of formic acid, the mobile phase with less formic acid achieved the best results confirming
that low-pH conditions created by high acid concentrations (up to 0.1%) decrease the negative-ion ESI
response by damaging the formation of the deprotonated analyte [22].
After the election of the mobile phase, several experiments with 50:50 (v/v) of (0.025% formic
acid)/MeCN (0.025% formic acid) were achieved to obtain the optimum DP, FP, EP, CE and the
quantification and confirmation transitions which are shown in Table 2. The results were similar
as those obtained in a previous validation method developed in HPLC-MS/MS [21].
Different linear gradient were proved to attain a good separation and resolution of the analytes.
The best results obtained for the conditions were described in the chromatographic separation section
with a total time run of 3.5 min. Diverse flow rates, 400, 600 and 800 µL/min, and injection volumes,
2, 5 and 10 µL were also studied to obtain a good separation and detection of the analytes. The
optimum flow rate was achieved in 600 µL/min, as in the HPLC-MS/MS method. 10 µL was
demonstrated to be the best injection volume to obtain the greatest detected peak height. The injection
volume was halved regarding to the HPLC-MS/MS method allowing more volume sample if various
injections were needed.
The time-saving and decrease in the total consumption of mobile phase implies a reduction in
analysis cost [20,23]. Compared with HPLC-MS/MS [21], the UHPLC-MS/MS method offered a
5-fold decrease in retention time (RT), up to 7-fold increase in detected peak height, and a 2-fold
decrease in peak width thereby enhancing the sensitivity of the method.
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3.2. Validation Parameters
The AOAC International criteria were consulted as to the validation of the method [24]. A
great improvement in terms of LOD and LOQ was achieved using UHPLC compared with HPLC
for almost all the studied phenolic compounds, in both plasma and urine (Table 3). In comparison
with our work, Rubió et al. [25] obtained higher LOD (1–240 ng/mL) and LOQ (3.3–801.5 ng/mL) in
the validation of an UHPLC-MS/MS system to detect plasma phenolic metabolites. In particular, our
method performed better for caffeic acid, with a LOD of 0.7 ng/mL compared to 64.9 in the study
of Rubió et al. [25]. 3,4-Dihydroxyphenylacetic acid and 3-(3-hydroxyphenyl)propionic acid followed
the same trend as caffeic acid, with lower values in our study (1.6 and 2.4 ng/mL, respectively),
compared to the data of Rubió et al. [25] (15.1 and 38.2 ng/mL, respectively). Another study, carried
out by Magiera et al. [16] to determine polyphenols and their metabolites in human urine by UHPLC
coupled to a 4000 Q TRAP triple quadrupole linear ion trap mass spectrometer, obtained a LOQ
for 3,4-dihydroxyphenylacetic acid comparable to our results, while other metabolites, for example,
caffeic acid, presented lower values (1 ng/mL) in comparison with our data (2.0 ng/mL). Lastly,
Oliveira et al. [26] reported the validation of a method that detected 11 phenolic acids in plasma,
urine and liver by an UHPLC system coupled to a single-quadrupole mass spectrometer. The LOQ
for caffeic, ferulic and 5-caffeoylquinic acids were 38, 52 and 52 ng/mL, respectively, in plasma, and
50, 96 and 48 ng/mL, respectively, in urine. Our study achieved a greater improvement in LOD in
comparison with Oliveira et al. [26].
Recovery results were similar to those reported by Rubió et al. [25], who found levels of 77%
for quercetin and 3,4-dihydroxyphenylacetic acid, and 98% for naringenin. Our data are also in
agreement with Magiera et al. [16], who reported recoveries between 91% and 100% for caffeic, ferulic,
and 3-hydroxyphenylacetic acids and naringenin. In another study on phenolic microbial metabolites
in humans and rats, the mean recovery of analytes ranged from 87% to 109% [27]. Our results are
therefore in agreement with the reported literature data.
Respect to accuracy and precision, a possible matrix effect may explain the higher values for
quercetin and 4-hydroxyhippuric acid, as peaks with good symmetry were obtained without tailing,
as can be seen in Figure 1. The proposed method therefore demonstrated good accuracy and precision
in both urine and plasma samples. The results were similar to those obtained by HPLC-MS/MS,
confirming that the method is applicable for the determination of phenolic compounds in both types
of biological samples. The high accuracy for homovanillic acid and phenylacetic acid, although still
within the limits established by the AOAC, may be due to their similar elution times, since they
practically co-eluted.
Finally, quercetin seems to be the phenolic compound most affected in terms of stability, either
in freeze/thaw or post-preparative studies. Ramešová et al. [28] reported that quercetin was
potentially affected by exposure to atmospheric oxygen conditions. Their study confirmed
the presence of four decomposition products by HPLC-DAD and HPLC-MS: 2-(31,41-
dihydroxybenzoyl)-2,4,6-trihydroxybenzofuran-3(2H)-one, 2-(3,4-dihydroxyphenyl)-2-oxoacetic
acid, 2,4,6-trihydroxybenzoic acid and 3,4-dihydroxybenzoic acid [28]. Although there was a
decrease in the stability of some polyphenols, there were no significant differences in either two
stability studies.
3.3. Phenolic Quantification in Tomato Sauce and Biological Samples
Three classes of polyphenols were quantified: 13 phenolic acids (three caffeoylquinic acids
and two derivatives; caffeic acid and two hexosides; one ferulic acid hexoside; two coumaric acid
hexosides; protocatechuic acid; and homovanillic acid hexoside), two flavanones (naringenin and
naringenin glucoside), and two flavonols (quercetin and rutin). Most of the polyphenols belong to
phenolic acids, being the homovanillic acid hexoside the major one in the tomato sauce. Naringenin
and rutin were the most abundant phenolic compounds preceding homovanillic acid hexoside.
Other authors have also described those as the three major polyphenols in tomato and tomato
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by-products [6,29–31]. Ferulic acid hexoside, caffeic acid hexoside I and 5-caffeoylquinic acid were
also present at high concentration, similarly to those obtained by Minoggio et al. [32] between 300 and
5800 ng/g FW. The validated method was successfully applied for the analysis of human plasma and
urine samples from the intervention study. The biological samples were screened for the phenolic
compounds previously analyzed in the validation study, identifying and quantifying the analytes
by comparing their MRM transition, RT, and product ion scan with those of the standards. Phase
II metabolites (glucuronide and sulfate conjugates) were also monitored to shed more light on the
metabolism of the target compounds. In the absence of standards, the phenolic metabolites were
identified by PIS, NL or PrIS (Table 4). Samples over the calibration curve were diluted and reinjected
in the UHPLC-MS/MS system. Polyphenols, when reached the intestine, are transformed in a wide
variety of phenolic metabolites [33,34], that are absorbed by the gut, circulated in the blood and
metabolized in the liver to glucuronides or sulfates metabolites [35]. Table 4 confirmed a great
metabolism of the phenolic compounds described in the tomato sauce as 12 phenolic compounds
were quantified in plasma and 28 in urine. Both, plasma and urine metabolites tripled the compounds
determined by HPLC-MS/MS [36]. Notably, isoferulic acid, caffeic acid sulfate, ferulic acid sulfate,
dihydrocaffeic acid metabolites and quercetin and its metabolites (glucuronide and sulfate), none of
which were identified by HPLC-MS/MS in either plasma or urine, were detected by UHPLC-MS/MS.
We can therefore report an efficient performance by the validated UHPLC method, as it allowed
the identification of phenolic compounds or metabolites undetected by the HPLC system, due to the
improvement in the limits of detection and quantification for almost all compounds.
4. Experimental Section
4.1. Chemicals
Caffeic acid, 5-caffeoylquinic acid, dihydrocaffeic acid, 3,4-dihydroxyphenylacetic acid,
ethylgallate (internal standard (IS)), ferulic acid, hippuric acid, homovanillic acid,
3-hydroxyphenylacetic acid, 3-hydroxybenzoic acid, isoferulic acid, naringenin, naringenin
glucoside, p-coumaric acid, protocatechuic acid, quercetin-3-O-glucuronide and rutin were
purchased from Extrasynthese (Genay, France); 3-(3-hydroxyphenyl)propionic acid, human
plasma, phenylacetic acid and quercetin were supplied by Sigma-Aldrich (St Louis, MO, USA);
and 4-hydroxyhippuric acid was purchased from PhytoLab GmbH & Co. KG. (Vestenbergsgreuth,
Germany). The purity of all standards was superior at 90%. All reagents were of HPLC grade:
ethanol (EtOH), acetonitrile (MeCN), methanol (MeOH), and o-phosphoric acid 85% were purchased
from Panreac Quimica S.A. (Barcelona, Spain); and formic acid was from Scharlau Chemie S.A.
(Barcelona, Spain). Ultrapure water (Milli-Q) was obtained from a Millipore system (Millipore,
Bedford, MA, USA).
4.2. Method Development
4.2.1. UHPLC Column
For the development of a faster chromatographic method, smaller particles and inner column
diameters are needed [37,38]. A Waters BEH C18 column (50 mm ˆ 2.1 mm) packed with 1.7 µm
particles using an Acquity UPLC BEH C18 VanGuard pre-column 1.7 µm (2.1 mm ˆ 5 mm) was
selected for the development of the UHPLC method instead of the Luna C18 (50 mm ˆ 2.0 mm) of
5 µm used for the analysis in the HPLC method [21].
4.2.2. Mobile Phase
The method validated in the HPLC-MS/MS system was adjusted to be used in the UHPLC
equipment. To obtain a better separation and resolution of the analytes, an aqueous mix of
15 commercial phenolic compounds (100 ng/mL final concentration) were analyzed, using the
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following mobile phase combinations: (1) [A] H2O (0.1% formic acid)/[B] MeCN (0.1% formic acid);
(2) [A] H2O (0.05% formic acid)/[B] MeCN (0.05% formic acid); and (3) [A] H2O (0.025% formic
acid)/[B] MeCN (0.025% formic acid).
4.2.3. MS Conditions
An API 3000 triple-quadrupole mass spectrometer (Sciex, Framingham, MA, USA) with a turbo
ion spray source controlled by Analyst v.1.4.2 software supplied by Sciex (Framingham, MA, USA,
version 1.4.2) was used for infusion experiments. 50:50 (v/v) of water (0.025% formic acid)/MeCN
(0.025% formic acid) was employed for infusion experiments, injecting each phenolic standard
individually at a concentration of 1 µg/mL. The Turbo Ion spray source was used in negative mode
with the following settings: capillary voltage,´3500 V; nebulizer gas (N2), 10 (arbitrary units); curtain
gas (N2), 12 (arbitrary units); drying gas (N2) was heated to 400 ˝C and introduced at a flow rate of
5000 cm3/min. Table 2 shows the optimal DP, FP, and EP to enhance the ESI detection of the target
phenolics. Multiple reaction monitoring (MRM) experiments in the negative ionization mode were
performed using a dwell time of 30 ms, with 434 cycles and between 10 to 14 data points on the
chromatographic peaks. The ions in MRM mode were produced by collision-activated dissociation
(CAD) of selected precursor ions in the collision cell of the triple quadrupole and analyzed with the
second analyzer of the instrument. The optimum collision-activated dissociation (N2) was 4 (arbitrary
units). The transition chosen for the quantification and confirmation are shown in Table 2 with its
appropriate CE.
4.2.4. Flow Rate and Volume of Injection
Once obtained the best mobile phase and the optimum mass conditions for each analyte, several
flow rates, 400, 600 and 800 µL/min, were studied at the same time that the volume of injection
comparing 2, 5 and 10 µL to enhance the separation and detection of the analytes.
4.2.5. Chromatographic Separation
The final mobile phase used was water (A) and MeCN (B) with 0.025% formic acid in both
solvents. An increasing linear gradient of B was used (t (min), %B), as follows: (0.0, 5); (2.0, 25);
(2.5, 90); (2.65, 100); (2.8, 100); (2.9, 5), and (3.5, 5). The mobile-phase flow rate for the biological
samples was 600 µL/min, and 10 µL of the sample was injected into the UHPLC system.
4.3. Quality Parameters
The method was validated following the criteria of AOAC International [24]. The quality
parameters established were LOD, LOQ, linearity, recovery, accuracy, precision, and stability.
LOD is the smallest quantity of analyte that can be shown to be significantly greater than the
measurement error of the blank at a prescribed level of confidence. The LOD was estimated from
the chromatograms of spiked blank plasma and urine samples at the lowest analyte concentration
tested for a signal-to-noise ratio of 3. Similarly, LOQ, the smallest amount of analyte in a test sample
that can be quantitatively determined with suitable precision and accuracy, was determined for a
signal-to-noise ratio of 10. Spiked plasma and urine samples at five different concentration levels,
ranged between 0.05 and 300 ng/mL, were prepared in triplicate in order to establish the LOD and
LOQ in the different mass spectrometric systems.
The IS method was used for the preparation of the calibration curves using eight different
concentrations within the range of the LOQ for each analyte to 576 times the LOQ. In order to
obtain the most reliable calibration curve, a 1/x or 1/(x ˆ x) weighting factor, or none, was
applied, according to the analyte. The calculated standard concentration was established within
15% deviation from the nominal value except at the LOQ concentration, for which the maximum
acceptable deviation was set at 20%.
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Recovery was assessed by preparing eight-point calibration curves (pre-extracted spiked
samples) and eight-point external curves (post-extracted spiked samples). To calculate recovery,
concentration must first be computed by interpolating areas obtained from the post-extracted spiked
samples into the pre-extracted spiked calibration curve. Then, the ratio analyte concentration/IS
concentration was plotted against the calculated concentration explained above and a linear
regression model was applied. The slope of the linear regression multiplied by 100 represents the
analyte recovery.
Accuracy was determined by spiking blank urine and plasma with three known concentrations:
low (3-fold the LOQ), medium (48-fold the LOQ), and high (288-fold the LOQ), with respect to the
calibration curves, in five replicates. The results were expressed as the percentage of the ratio of the
mean concentration observed and the known spiked concentration in the biological matrices. The
mean value should be within 15% of the nominal value. Intra- and interday precision was assessed
using five determinations per three concentration levels (low (3-fold the LOQ), medium (48-fold the
LOQ), and high (288-fold the LOQ)) in a single analytical run or on three different days, respectively.
The precision determined at each concentration level should not exceed 15% of the relative standard
deviation (RSD).
The chemical stability of an analyte in a given matrix under specific conditions for given time
intervals is assessed in several ways. Stability evaluations should cover the expected sample handling
and storage conditions during the length of the study. The factors studied in this method were
freeze-thaw cycle stability and processed sample stability.
4.4. Method Application: Pilot Dietary Intervention Study
4.4.1. Biological Material
The optimized method was applied to a small-scale prospective single-arm intervention study
conducted in eight volunteers aged between 19 and 38 years (28 ˘ 6.9 years) with a mean body mass
index of 23 ˘ 3.73 kg/m2. On the day of intervention, the volunteers consumed 250 mL of tomato
sauce per 70 kg of body weight. Blood was collected 1 h and urine 3–6 h after the consumption of the
intervention and stored at ´80 ˝C until analysis.
Commercial tomatoes (Lycopersicum esculentum L.) were used for the elaboration of the tomato
sauce at the Torribera Campus, University of Barcelona (Santa Coloma de Gramanet, Barcelona)
following a standardized making process [36].
The study protocol was approved by the Ethics Committee of Clinical Investigation of the
University of Barcelona (Spain), and the clinical trial was registered at the International Standard
Randomized Controlled Trial Number (ISRCTN20409295). Informed consent was obtained from
all participants.
4.4.2. Phenolics of Tomato Sauce and Biological Samples Extraction
A liquid-liquid extraction with ethanol/H2O (0.1% formic acid) (80/20, v/v) was used to extract
the phenolic compounds from the tomato sauce, as previously described by Di Lecce et al. [7]. Briefly,
tomato sauce (0.3 g) was weighed and ethanol/H2O (0.1% formic acid) (80/20, v/v, 3 mL) added.
The homogenate was sonicated for 5 min and centrifuged at 4000 rpm for 20 min at 4 ˝C. The
supernatant was collected, and the extraction procedure was repeated. Both supernatants were
combined and the ethanol phase evaporated under a stream of nitrogen gas. The residues were
reconstituted up to 1.2 mL with water containing 0.1% formic acid, filtered thought a 0.22 µm
polytetrafluoroethylene (PTFE) syringe filters (Waters Corporation, Mildfore, MA, USA), and injected
into the UHPLC-MS/MS system. Extractions were performed in triplicate and quantified with the
corresponding commercial standards. When standards were not available, as in the case of di-,
tricaffeoylquinics and the hexoside isomers, the compounds were quantified based on the free form
of the corresponding metabolite.
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Phenolic compounds were extracted from both plasma and urine samples by solid phase
extraction (SPE) as previously described by our research group with minor modifications [21].
Prior to the SPE, plasma and urine samples were acidified with o-phosphoric acid and formic acid,
respectively, and urine samples were centrifuged at 11,884 rpm for 4 min at 4 ˝C. Then, MeOH (1 mL)
and 1.5 M formic acid (1 mL) was added to activate the HLB plate 30 µm (30 mg). Plasma or urine
sample (1 mL), previously acidified and spiked with ethyl gallate (IS), was loaded into the 96-well
plate for clean-up with 1.5 M formic acid (1 mL) and 5% MeOH solution (1 mL). The elution was
achieved with MeOH (1 mL) acidified with 0.1% formic acid. The elution fraction obtained was
evaporated to dryness by a sample concentrator (Techne, Staffordshire, UK) at room temperature
under a stream of nitrogen. 100 µL of water acidified with 0.1% formic acid was added to dissolve
the residue and filtered through a 0.22 µm polytetrafluoroethylene (PTFE) syringe filters (Waters
Corporation).
5. Conclusions
We have validated an UHPLC-MS/MS method to determine tomato phenolics and their
metabolites in biological samples with a previous solid phase extraction capable of analyzing a high
number of samples in a short period of time. To our knowledge, this is the first method reported
for the rapid detection and quantification of tomato sauce phenolics and their microbiota-derived
metabolites in plasma and urine samples. The method offers excellent sensitivity, reproducibility and
recovery. This procedure, due to its rapidity and simplicity, can be applied in future clinical and
epidemiological studies with a high number of blood and urine samples.
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